Form 4 for HRTX HERON THERAPEUTICS, INC. /DE/
Accepted 2022-10-17 00:00:00 ET · period of report 2022-10-13 · accession 0001209191-22-053827 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-10-17 | 2022-10-13 | HRTX | MANHARD KIMBERLY | EVP, Drug Development, Dir | M - OptEx | — | +5,814 | 20.5K | +40% | — |
| D | 2022-10-17 | 2022-10-13 | HRTX | MANHARD KIMBERLY | EVP, Drug Development, Dir | F - Tax | $3.76 | -2,012 | 18.5K | -10% | -$7,565 |
| DM | 2022-10-17 | 2022-10-13 | HRTX | MANHARD KIMBERLY | EVP, Drug Development, Dir | M - OptEx | $0.00 | -5,814 | 37.1K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-13 | M | A | 1,250 | — | 15,924 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2022-10-13 | F | D | 2,012 | $3.76 | 18,476 | D | — | — | (F2) Represents the withholding by the Company of certain of the vested shares of restricted stock to satisfy the minimum statutory tax obligations applicable to such transactions. |
| 3 | Common | Common Stock | 2022-10-13 | M | A | 4,564 | — | 20,488 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 4 | Derivative | Restricted Stock Units | 2022-10-13 | M | D | 1,250 | $0.00 | 10,000 | D | — · — to — | 1,250 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F3) The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (10/13/2020). |
| 5 | Derivative | Restricted Stock Units | 2022-10-13 | M | D | 4,564 | $0.00 | 37,064 | D | — · — to — | 4,564 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) The restricted stock units vest quarterly with 33% of the shares vesting during the first year, 33% of the shares vesting during the second year, 22% of the shares vesting during the third year and the remaining 12% of the shares vesting during the fourth year, such that all shares will be fully vested on the four year anniversary of the date of grant (10/13/2021). |